Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer

BACKGROUND: With the improvement of therapeutic strategies from cytotoxic chemotherapy to immunotherapy, the possibility of achieving timely intervention for lung cancer has dramatically increased. This study aimed to systematically evaluate the reporting quality of randomized controlled trials (RCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Jun, Zhang, Yundi, Dong, Yiting, Duan, Jianchun, Bai, Hua, Wang, Jie, Xu, Jiachen, Wang, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520800/
https://www.ncbi.nlm.nih.gov/pubmed/34432361
http://dx.doi.org/10.1111/1759-7714.14114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520800/
https://www.ncbi.nlm.nih.gov/pubmed/34432361
http://dx.doi.org/10.1111/1759-7714.14114

Ejemplares similares